Bio Green Med Solution, Inc. (BGMS)

Official site

INDUSTRIALS • NONE • NASDAQ

$0.88

-0.02 (-1.77%)

Market Cap: $5.92M

Last updated: Oct 16, 2026 at 1:54 PM ET

Earnings

Performance (10Y)

Beat Rate

62%(18/29)

Avg Surprise

-12589.63%

Streak

4 Q

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Jun 30, 2026Jun 26 Reported Aug 13, 2026Reported Aug 13	$-0.08	N/A	-	N/A	Beat	-	-	+75.8%
Mar 31, 2026Mar 26 Reported May 14, 2026Reported May 14	$-0.04	N/A	-	N/A	Beat	-	-	+99.9%
Sep 30, 2025Sep 25 Reported Nov 13, 2025Reported Nov 13	$-1.31	N/A	-	N/A	Beat	-	-	+99.2%
Jun 30, 2025Jun 25 Reported Aug 14, 2025Reported Aug 14	$-1.53	N/A	-	N/A	Beat	-	-	+99.7%
Mar 31, 2025Mar 25 Reported Apr 2, 2025Reported Apr 2	$-0.33	N/A	-	+94.57%	Beat	-	-	+100.0%
Sep 30, 2024Sep 24 Reported Nov 12, 2024Reported Nov 12	$-43.20	N/A	-	+66.67%	Beat	-	-	+97.6%
Jun 30, 2024Jun 24 Reported Aug 14, 2024Reported Aug 14	$-172.80	$-344.40	-	+49.83%	Beat	-	-	+89.1%
Mar 31, 2024Mar 24 Reported May 14, 2024Reported May 14	$-544.80	N/A	-	+53.96%	Beat	-	-	+67.8%
Dec 31, 2023Dec 23 Reported Mar 27, 2024Reported Mar 27	$-1495.31	$-0.41	-	-361697.41%	Miss	-	-	-249118.1%
Sep 30, 2023Sep 23 Reported Nov 13, 2023Reported Nov 13	$-1764.00	$-1350.00	-	-30.67%	Miss	-	-	-16.7%
Jun 30, 2023Jun 23 Reported Aug 9, 2023Reported Aug 9	$-1584.00	$-1944.00	-	+18.52%	Beat	-	-	+4.3%
Mar 31, 2023Mar 23 Reported May 11, 2023Reported May 11	$-1692.00	$-2430.00	-	+30.37%	Beat	-	-	-11.9%
Dec 31, 2022Dec 22 Reported Mar 6, 2023Reported Mar 6	$-0.60	$-0.48	-	-25.00%	Miss	-	-	-11.1%
Sep 30, 2022Sep 22 Reported Nov 9, 2022Reported Nov 9	$-1512.00	$-1740.00	-	+13.10%	Beat	-	-	+22.2%
Jun 30, 2022Jun 22 Reported Aug 10, 2022Reported Aug 10	$-1656.00	$-2400.00	-	+31.00%	Beat	-	-	+17.9%
Mar 31, 2022Mar 22 Reported May 11, 2022Reported May 11	$-1512.00	$-2424.00	-	+37.62%	Beat	-	-	+16.0%
Dec 31, 2021Dec 21 Reported Mar 28, 2022Reported Mar 28	$-0.54	$-0.69	-	+21.17%	Beat	-	-	+59.7%
Sep 30, 2021Sep 21 Reported Nov 10, 2021Reported Nov 10	$-1944.00	$-2520.00	-	+22.86%	Beat	-	-	-14.9%
Jun 30, 2021Jun 21 Reported Aug 11, 2021Reported Aug 11	$-2016.00	$-1692.00	-	-19.15%	Miss	-	-	+3.4%
Mar 31, 2021Mar 21 Reported May 12, 2021Reported May 12	$-1800.00	$-1620.00	-	-11.11%	Miss	-	-	+66.2%
Dec 31, 2020Dec 20 Reported Feb 25, 2021Reported Feb 25	$-1.34	$-0.53	-	-152.83%	Miss	-	-	+52.1%
Sep 30, 2020Sep 20 Reported Nov 11, 2020Reported Nov 11	$-1692.00	$-1764.00	-	+4.08%	Beat	-	-	+78.6%
Jun 30, 2020Jun 20 Reported Aug 12, 2020Reported Aug 12	$-2088.00	$-1584.00	-	-31.82%	Miss	-	-	+73.6%
Mar 31, 2020Mar 20 Reported May 12, 2020Reported May 12	$-5327.99	$-10079.99	-	+47.14%	Beat	-	-	+47.1%
Dec 31, 2019Dec 19 Reported Feb 26, 2020Reported Feb 26	$-2.80	$-0.14	-	-1900.00%	Miss	-	-	+12.5%
Sep 30, 2019Sep 19 Reported Nov 13, 2019Reported Nov 13	$-7919.99	$-11879.99	-	+33.33%	Beat	-	-	+38.9%
Jun 30, 2019Jun 19 Reported Aug 13, 2019Reported Aug 13	$-7919.99	$-10799.99	-	+26.67%	Beat	-	-	+31.3%
Mar 31, 2019Mar 19 Reported May 14, 2019Reported May 14	$-10079.99	$-13679.99	-	+26.32%	Beat	-	-	-16.7%
Dec 31, 2018Dec 18 Reported Mar 27, 2019Reported Mar 27	$-3.20	$-0.17	-	-1782.35%	Miss	-	-	+0.0%
Sep 30, 2018Sep 18 Reported Nov 12, 2018Reported Nov 12	$-12959.99	$-12239.99	-	-5.88%	Miss	-	-	-71108.7%
Jun 30, 2018Jun 18 Reported Aug 9, 2018Reported Aug 9	$-11519.99	$-8639.99	-	-33.33%	Miss	-	-	-2303898.0%
Mar 31, 2018Mar 18 Reported May 14, 2018Reported May 14	$-8639.99	$-9359.99	-	+7.69%	Beat	-	-	-2273581.6%
Dec 31, 2017Dec 17 Reported Mar 28, 2018Reported Mar 28	$-3.20	N/A	-	N/A	Beat	-	-	+100.0%
Sep 30, 2017Sep 17 Reported Nov 9, 2017Reported Nov 9	$-18.20	N/A	-	N/A	Beat	-	-	-
Jun 30, 2017Jun 17 Reported Aug 9, 2017Reported Aug 9	$-0.50	N/A	-	N/A	Beat	-	-	-
Mar 31, 2017Mar 17 Reported May 10, 2017Reported May 10	$-0.38	N/A	-	N/A	Beat	-	-	-
Dec 31, 2016Dec 16 Reported Mar 28, 2017Reported Mar 28	$-49679.95	$-52559.95	-	+5.48%	Beat	-	-	-

Dividends

Dividend Metrics

Forward Yield0.00%

Forward Annual Dividend$0.00

Key Metrics

Valuation
P/E Ratio	N/A	EV/EBITDA	N/A
Price/FCF	N/A	FCF Yield	N/A
Profitability
Profit Margin	-118.30%	Operating Margin	-124.40%
ROE	34.40%	ROIC	N/A
Financial Health
Debt/Equity	0.00x	Interest Coverage	30.96x
Current Ratio	8.63x	Quick Ratio	7.22x
Trading Statistics
Beta	-0.38	Avg Volume	30.64K
52-Week High	$4.11	52-Week Low	$0.57

Technical Indicators Dashboard

Moving Averages

SMA 10$0.88

SMA 20$0.90

SMA 50$0.90

SMA 200$0.99

EMA 10$0.89

EMA 20$0.89

EMA 50$0.90

EMA 200$2.44

MACD

Line: -0.00Signal: -0.00Hist: 0.00

ADX

ADX: 25.8+DI: 24.5-DI: 15.3

Aroon & PSAR

Aroon Up12.0

Aroon Down8.0

PSAR$1.04

Bollinger Bands

Upper Band$0.99

Lower Band$0.81

%B Position1911%(Upper)

Band Width0.37

RSI (14-Day)

Neutral

48.1

Momentum Oscillators

Stoch %K34.9

Stoch %D42.7

Williams %R-71.9

ROC (10d)-2.8%

Momentum-0.03

CCI (20d)-80.8

MFI (14d)63.5

Volatility Measures

ATR (14d)$0.08(9.2%)

StdDev (20d)0.04

Hist Vol78.3%(High)

Volume Flow

VWAP$0.86

OBV314.7M

AD Line163.8B

CMF (20d)0.038

Volume Metrics

Avg Vol (20d)30.6K

Vol Ratio0.5x(Low)

VWMA (20d)$0.94

Pivot Points

R3$0.97

R2$0.94

R1$0.92

Pivot Point$0.89

S1$0.86

S2$0.83

S3$0.81

Advanced Oscillators

TSI-1.63

Ultimate Osc48.1

KST-22.98

Financial Data

Quarter	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total Revenue	$336,000	$778,000	$666,000	$81,000	$0	$0	$0	$10,000	$0	$0	$388,000	$32,000
Cost of Revenue	$257,000	$635,000	$545,000	$64,000	$0	$0	$1,000	$0	$0	$0	$8,000	$0
Gross Profit	$79,000	$143,000	$121,000	$17,000	$0	$0	$-1,000	$10,000	$0	$0	$388,000	$32,000

Operating Expenses	$497,000	$389,000	$1.20M	$1.01M	$1.25M	$4.21M	$1.83M	$2.19M	$3.65M	$4.38M	$8.04M	$6.86M
R&D	$0	$0	$-47,000	$5,000	$0	$0	$880,000	$950,000	$2.02M	$2.80M	$6.22M	$5.24M
SG&A	$497,000	$389,000	$1.25M	$1.00M	$1.25M	$4.21M	$948,000	$1.24M	$1.63M	$1.58M	$1.82M	$1.63M
Operating Income	$-418,000	$-246,000	$-1,082,000	$-992,000	$-1,249,000	$-4,214,000	$-1,828,000	$-2,177,000	$-3,644,000	$-4,355,000	$-7,645,000	$-6,845,000

Interest Income	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Interest Expense	$-9,000	$-9,000	$-45,000	$-9,000	$-2,000	$-6,000	$30,000	$-8,000	$28,000	$-2,000	$413,000	$0
Income Before Tax	$-396,000	$-167,000	$-606,000	$-988,000	$-1,248,000	$-4,206,000	$-1,858,000	$-2,167,000	$-3,669,000	$-4,300,000	$-8,058,000	$-6,700,000
Income Tax Expense	$9,000	$30,000	$5,000	$0	$2,000	$0	$1.19M	$-210,000	$-412,000	$-1,354,000	$-596,000	$-668,000

Net Income	$-405,000	$-197,000	$-611,000	$-988,000	$-1,318,000	$-81,000	$-3,052,000	$-1,957,000	$-3,257,000	$-2,946,000	$-7,462,000	$-6,032,000

EBITDA	$-405,000	$-175,000	$-647,000	$-997,000	$-1,249,000	$-4,212,000	$-1,885,000	$-2,175,000	$-3,645,000	$-4,300,000	$-8,178,000	$-6,731,000
EBIT	$-405,000	$-176,000	$-651,000	$-997,000	$-1,250,000	$-4,212,000	$-1,886,000	$-2,175,000	$-3,641,000	$-4,302,000	$-8,186,000	$-6,750,000

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about BGMS

News

Bio Green Med Solution, Inc. SEC Filing (Oct 9, 2026)

Bio Green Med Solution, Inc. (NASDAQ: BGMS) filed an S-4 Form with the SEC, which became effective on October 8, 2026...

Stock Titan•Oct 9, 2026 7:54 AM ET10/9/26•Neutral

Bio Green Med Solution stock reports Q2 revenue of USD 336,000

Bio Green Med Solution (BGMS) reported a significant decline in Q2 2026 revenue to USD 336,000, a 56.81% sequential drop from the previous quarter, and a widened net loss of USD 405,000. The company...

AD HOC NEWS•Oct 7, 2026 12:09 AM ET10/7/26•Bearish

Bio Green Med Solution stock reports Q2 loss as shares fall

Bio Green Med Solution (BGMS) stock fell by 2.69% to USD 0.88 on October 2, 2026, following a Q2 2026 report showing a significant loss. The company's Q2 revenue dropped to USD 336,000...

AD HOC NEWS•Oct 4, 2026 7:50 PM ET10/4/26•Bearish

BGMS Forecast — Price Target — Prediction for 2027

This article provides a forecast and price target for Bio Green Med Solution, Inc. (BGMS) for 2027, along with historical price data and financial metrics. It also addresses frequently asked questions about the company's...

TradingView•Sep 30, 2026 3:00 PM ET9/30/26•Neutral

ACT NOW: The M&A Class Action Firm Is Investigating the Merger— ATKR, BZH, BGMS and CBAN

Monteverde & Associates PC, a class action firm, is investigating several mergers involving Atkore Inc. (ATKR), Beazer Homes USA, Inc. (BZH), Bio Green Med Solution, Inc. (BGMS), and Colony Bankcorp...

Morningstar•Sep 28, 2026 3:14 PM ET9/28/26•Neutral

BGMS Valuation and Fair Value

P/B: 0.7x

See GNG's fair value

BGMS Profitability: Margins, ROIC and FCF

Gross margin: 19.3%
Operating margin: -124.4%
Net margin: -118.3%
ROE: 34.4%
FCF margin: -59.0%

BGMS Competitors

Company	Ticker
Intelligent Living Application Group Inc	ILAG
Ocean Power Technologies Inc	OPTT
Nixxy, Inc.	NIXX
Masonglory Limited Ordinary Shares	MSGY
ESS Tech Inc	GWH
Galaxy Payroll Group Limited Ordinary Shares	GLXG
Rail Vision Ltd. Ordinary Share	RVSN
CCSC Technology International Holdings Limited Ordinary Shares	CCTG

Sector: Industrials

BGMS Bull Case vs Bear Case

Bull case

BGMS beat EPS estimates in 75.0% of its last 8 reported quarters.
BGMS grew quarterly revenue 710.0% year over year.

Bear case

BGMS has a -118.3% net profit margin.

BGMS Earnings: Beat Rate and Next Report

Beat rate: 6 of 8 quarters (75.0%)
Average surprise: 40.5%

BGMS Dividend

Forward yield: 0.0%

Frequently Asked Questions About BGMS

Does BGMS pay dividends?

Bio Green Med Solution, Inc. (BGMS) has a dividend payment track record. See the BGMS dividend history page for its current payment status, TTM yield, and recorded payments.

What is BGMS's market cap?

Bio Green Med Solution, Inc. (BGMS) has a market capitalization of $5.92M with a current stock price of $0.88.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In